APA

Kopylov U., Mantzaris G. J., Katsanos K. H., Reenaers C., Ellul P., Rahier J. F., Israeli E., Lakatos P. L., Fiorino G., Cesarini M., Tsianos E. V., Louis E. & Ben-Horin S. (20110603). The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. : Alimentary pharmacology & therapeutics.

Chicago

Kopylov U, Mantzaris G J, Katsanos K H, Reenaers C, Ellul P, Rahier J F, Israeli E, Lakatos P L, Fiorino G, Cesarini M, Tsianos E V, Louis E and Ben-Horin S. 20110603. The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. : Alimentary pharmacology & therapeutics.

Harvard

Kopylov U., Mantzaris G. J., Katsanos K. H., Reenaers C., Ellul P., Rahier J. F., Israeli E., Lakatos P. L., Fiorino G., Cesarini M., Tsianos E. V., Louis E. and Ben-Horin S. (20110603). The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. : Alimentary pharmacology & therapeutics.

MLA

Kopylov U, Mantzaris G J, Katsanos K H, Reenaers C, Ellul P, Rahier J F, Israeli E, Lakatos P L, Fiorino G, Cesarini M, Tsianos E V, Louis E and Ben-Horin S. The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. : Alimentary pharmacology & therapeutics. 20110603.